{"id":71762,"date":"2026-04-15T14:12:41","date_gmt":"2026-04-15T08:42:41","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=71762"},"modified":"2026-04-15T14:12:43","modified_gmt":"2026-04-15T08:42:43","slug":"torrent-pharma-share-price-target-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/torrent-pharma-share-price-target-2026\/","title":{"rendered":"Torrent Pharmaceuticals Share Price Target 2026: Analyst Forecast, Bull &amp; Bear Case"},"content":{"rendered":"<p><strong>Torrent Pharmaceuticals<\/strong> (NSE: TORNTPHARM) trades at Rs 2,850 as of April 2026 \u2014 against a 52-week high of Rs 3,700 and a 52-week low of Rs 2,600. The analyst consensus 12-month Torrent Pharmaceuticals share price target is Rs 3,300\u20133,700, implying 16\u201330% upside. This article covers the key catalysts, risks, financial positioning, and a structured bull\/bear case share price target for 2026 and beyond.<\/p><p>Get free SEBI-registered analyst research on <strong>Torrent Pharmaceuticals<\/strong> on <a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Univest<\/strong><\/a>.<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharma-share-price-target-2026\/#Torrent_Pharmaceuticals_Share_Price_%E2%80%94_Snapshot\" title=\"Torrent Pharmaceuticals Share Price \u2014 Snapshot\">Torrent Pharmaceuticals Share Price \u2014 Snapshot<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharma-share-price-target-2026\/#About_Torrent_Pharmaceuticals\" title=\"About Torrent Pharmaceuticals\">About Torrent Pharmaceuticals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharma-share-price-target-2026\/#Key_Growth_Catalysts_%E2%80%94_Torrent_Pharmaceuticals_Share_Price_Target\" title=\"Key Growth Catalysts \u2014 Torrent Pharmaceuticals Share Price Target\">Key Growth Catalysts \u2014 Torrent Pharmaceuticals Share Price Target<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharma-share-price-target-2026\/#1_India_Branded_Generic_Cardiology\" title=\"1. India Branded Generic Cardiology\">1. India Branded Generic Cardiology<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharma-share-price-target-2026\/#2_Germany_Acquisition\" title=\"2. Germany Acquisition\">2. Germany Acquisition<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharma-share-price-target-2026\/#3_MR_Expansion\" title=\"3. MR Expansion\">3. MR Expansion<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharma-share-price-target-2026\/#Key_Risks_to_Watch\" title=\"Key Risks to Watch\">Key Risks to Watch<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharma-share-price-target-2026\/#Risk_1_Germany_generic_price_erosion_on_key_portfolio_products\" title=\"Risk 1: Germany generic price erosion on key portfolio products\">Risk 1: Germany generic price erosion on key portfolio products<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharma-share-price-target-2026\/#Risk_2_Limited_US_branded_generic_pipeline_vs_peers\" title=\"Risk 2: Limited US branded generic pipeline vs peers\">Risk 2: Limited US branded generic pipeline vs peers<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharma-share-price-target-2026\/#Torrent_Pharmaceuticals_Share_Price_Target_2026\" title=\"Torrent Pharmaceuticals Share Price Target 2026\">Torrent Pharmaceuticals Share Price Target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharma-share-price-target-2026\/#Short-Term_Target_3%E2%80%936_Months\" title=\"Short-Term Target (3\u20136 Months)\">Short-Term Target (3\u20136 Months)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharma-share-price-target-2026\/#12-Month_Analyst_Consensus_Target\" title=\"12-Month Analyst Consensus Target\">12-Month Analyst Consensus Target<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharma-share-price-target-2026\/#Long-Term_Target_FY27%E2%80%93FY28\" title=\"Long-Term Target (FY27\u2013FY28)\">Long-Term Target (FY27\u2013FY28)<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharma-share-price-target-2026\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharma-share-price-target-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharma-share-price-target-2026\/#Q_What_is_Torrent_Pharmaceuticals_share_price_target_for_2026\" title=\"Q: What is Torrent Pharmaceuticals share price target for 2026?\">Q: What is Torrent Pharmaceuticals share price target for 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharma-share-price-target-2026\/#Q_What_is_Torrent_Pharmaceuticalss_current_share_price\" title=\"Q: What is Torrent Pharmaceuticals&#8217;s current share price?\">Q: What is Torrent Pharmaceuticals&#8217;s current share price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharma-share-price-target-2026\/#Q_Is_Torrent_Pharmaceuticals_a_good_buy_at_current_levels\" title=\"Q: Is Torrent Pharmaceuticals a good buy at current levels?\">Q: Is Torrent Pharmaceuticals a good buy at current levels?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharma-share-price-target-2026\/#Q_What_are_the_key_risks_for_Torrent_Pharmaceuticals\" title=\"Q: What are the key risks for Torrent Pharmaceuticals?\">Q: What are the key risks for Torrent Pharmaceuticals?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharma-share-price-target-2026\/#Q_What_is_Torrent_Pharmaceuticalss_market_cap_and_PE\" title=\"Q: What is Torrent Pharmaceuticals&#8217;s market cap and P\/E?\">Q: What is Torrent Pharmaceuticals&#8217;s market cap and P\/E?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharma-share-price-target-2026\/#Q_What_are_Torrent_Pharmaceuticalss_growth_catalysts\" title=\"Q: What are Torrent Pharmaceuticals&#8217;s growth catalysts?\">Q: What are Torrent Pharmaceuticals&#8217;s growth catalysts?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharma-share-price-target-2026\/#Q_What_is_Torrent_Pharmaceuticalss_long-term_target\" title=\"Q: What is Torrent Pharmaceuticals&#8217;s long-term target?\">Q: What is Torrent Pharmaceuticals&#8217;s long-term target?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharma-share-price-target-2026\/#Q_Where_can_I_track_Torrent_Pharmaceuticals_live\" title=\"Q: Where can I track Torrent Pharmaceuticals live?\">Q: Where can I track Torrent Pharmaceuticals live?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharma-share-price-target-2026\/#Recent_Articles\" title=\"Recent Articles\">Recent Articles<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Torrent_Pharmaceuticals_Share_Price_%E2%80%94_Snapshot\"><\/span><strong>Torrent Pharmaceuticals Share Price \u2014 Snapshot<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Parameter<\/strong><\/td><td><strong>Value<\/strong><\/td><\/tr><tr><td>CMP (April 2026)<\/td><td>Rs 2,850<\/td><\/tr><tr><td>52-Week High<\/td><td>Rs 3,700<\/td><\/tr><tr><td>52-Week Low<\/td><td>Rs 2,600<\/td><\/tr><tr><td>Market Cap<\/td><td>Rs 96,000 Cr<\/td><\/tr><tr><td>Trailing P\/E<\/td><td>40x<\/td><\/tr><tr><td>NSE Ticker<\/td><td>TORNTPHARM<\/td><\/tr><tr><td>Sector<\/td><td>Pharma \/ Branded Generics \/ Germany<\/td><\/tr><tr><td>12M Analyst Target<\/td><td>Rs 3,300\u20133,700<\/td><\/tr><tr><td>Bull Case<\/td><td>Rs 4,500<\/td><\/tr><tr><td>Bear Case<\/td><td>Rs 2,200<\/td><\/tr><tr><td>Upside (12M)<\/td><td>16\u201330%<\/td><\/tr><\/tbody><\/table><\/figure><p>Track <strong>Torrent Pharmaceuticals<\/strong> live on the <a href=\"https:\/\/univest.in\/screeners\"><strong>Univest Screener<\/strong><\/a> \u2014 fundamentals, FII\/DII flows, analyst ratings.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"About_Torrent_Pharmaceuticals\"><\/span><strong>About Torrent Pharmaceuticals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here \u2014 Get Free Investment Predictions on Univest<\/strong><\/a>.<\/p><p>Torrent Pharmaceuticals is India&#8217;s fifth-largest pharma company \u2014 with branded generic leadership in cardiology (Nikoran, Dilzem), CNS, and GI segments in India. Germany and Brazil contribute 25% of revenue from established generic markets.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Key_Growth_Catalysts_%E2%80%94_Torrent_Pharmaceuticals_Share_Price_Target\"><\/span><strong>Key Growth Catalysts \u2014 Torrent Pharmaceuticals Share Price Target<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Tap to Access Best Research Pieces on Univest<\/strong><\/a>.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"1_India_Branded_Generic_Cardiology\"><\/span><strong>1. India Branded Generic Cardiology<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>India Branded Generic Cardiology \u2014 8% Market Share in Rs 50,000 Cr Market<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"2_Germany_Acquisition\"><\/span><strong>2. Germany Acquisition<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Germany Acquisition \u2014 Integrating Hensinki Pharma Adding EUR 40 Mn Revenue<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"3_MR_Expansion\"><\/span><strong>3. MR Expansion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>MR Expansion \u2014 10,000 Field Force Targeting Tier 2 Markets<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Key_Risks_to_Watch\"><\/span><strong>Key Risks to Watch<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Risk_1_Germany_generic_price_erosion_on_key_portfolio_products\"><\/span><strong>Risk 1: Germany generic price erosion on key portfolio products<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Germany generic price erosion on key portfolio products<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Risk_2_Limited_US_branded_generic_pipeline_vs_peers\"><\/span><strong>Risk 2: Limited US branded generic pipeline vs peers<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Limited US branded generic pipeline vs peers<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Torrent_Pharmaceuticals_Share_Price_Target_2026\"><\/span><strong>Torrent Pharmaceuticals Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Subscribe to Univest Pro<\/strong><\/a> for premium analyst research on Torrent Pharmaceuticals.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Short-Term_Target_3%E2%80%936_Months\"><\/span><strong>Short-Term Target (3\u20136 Months)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>In the near term, Torrent Pharmaceuticals is expected to trade in the Rs 2,600\u2013Rs 3 range pending Q4 FY26 results and FY27 guidance clarity. The 52-week low of Rs 2,600 is the primary downside reference for position management.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"12-Month_Analyst_Consensus_Target\"><\/span><strong>12-Month Analyst Consensus Target<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>The analyst consensus 12-month Torrent Pharmaceuticals share price target is Rs 3,300\u20133,700 \u2014 implying 16\u201330% upside from Rs 2,850. This consensus assumes the primary catalysts materialise and macro conditions stabilise. These are analyst projections, not guaranteed returns. Check live targets on the Univest Screener.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Long-Term_Target_FY27%E2%80%93FY28\"><\/span><strong>Long-Term Target (FY27\u2013FY28)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>The Torrent Pharmaceuticals long-term target is Rs 4,500 in the bull case for FY27\u201328 \u2014 achievable if earnings delivery is consistent and catalysts accelerate. The bear case of Rs 2,200 represents the risk scenario if primary headwinds persist.<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Scenario<\/strong><\/td><td><strong>Target Price<\/strong><\/td><td><strong>Key Assumption<\/strong><\/td><\/tr><tr><td>Bear<\/td><td>Rs 2,200<\/td><td>Headwinds persist; earnings miss; macro adverse<\/td><\/tr><tr><td>Base (12M)<\/td><td>Rs 3,300\u20133,700<\/td><td>Catalysts deliver; earnings in line; macro stabilises<\/td><\/tr><tr><td>Bull<\/td><td>Rs 4,500<\/td><td>Catalysts accelerate; beat; sector re-rates<\/td><\/tr><\/tbody><\/table><\/figure><p>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> for live Torrent Pharmaceuticals price and SEBI-registered analyst alerts.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Torrent Pharmaceuticals at Rs 2,850 offers risk-reward of 16\u201330% to the 12-month analyst consensus of Rs 3,300\u20133,700. The bull case of Rs 4,500 is achievable on full catalyst delivery; the bear case Rs 2,200 is the downside reference. Track Q4 FY26 results and FY27 management guidance as the primary near-term catalysts for validating the Torrent Pharmaceuticals share price target thesis.<\/p><p>For more stock research, visit <a href=\"https:\/\/univest.in\/blogs\">Univest Blogs<\/a>.<\/p><p><strong>Disclaimer: <\/strong>This article is for informational and educational purposes only and does not constitute investment advice. All analyst targets are estimates based on publicly available data as of April 2026. Investments in securities are subject to market risk. Please consult a SEBI-registered financial advisor before making any investment decisions.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_What_is_Torrent_Pharmaceuticals_share_price_target_for_2026\"><\/span><strong>Q: What is Torrent Pharmaceuticals share price target for 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>The 12-month analyst consensus Torrent Pharmaceuticals share price target is Rs 3,300\u20133,700, implying 16\u201330% upside from Rs 2,850. Bull case is Rs 4,500; bear case is Rs 2,200. These are analyst projections, not guaranteed returns.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_What_is_Torrent_Pharmaceuticalss_current_share_price\"><\/span><strong>Q: What is Torrent Pharmaceuticals&#8217;s current share price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Torrent Pharmaceuticals (NSE: TORNTPHARM) trades at Rs 2,850 as of April 2026. 52-week high is Rs 3,700; 52-week low is Rs 2,600. Market cap is Rs 96,000 Cr.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_Is_Torrent_Pharmaceuticals_a_good_buy_at_current_levels\"><\/span><strong>Q: Is Torrent Pharmaceuticals a good buy at current levels?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>This article does not constitute investment advice. Torrent Pharmaceuticals at Rs 2,850 has an analyst consensus target of Rs 3,300\u20133,700 implying 16\u201330% upside. Review catalysts and risks above and consult a SEBI-registered financial advisor before investing.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_What_are_the_key_risks_for_Torrent_Pharmaceuticals\"><\/span><strong>Q: What are the key risks for Torrent Pharmaceuticals?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Primary risks: Germany generic price erosion on key portfolio products. Additionally: Limited US branded generic pipeline vs peers. Review the full risk analysis section for details.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_What_is_Torrent_Pharmaceuticalss_market_cap_and_PE\"><\/span><strong>Q: What is Torrent Pharmaceuticals&#8217;s market cap and P\/E?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Torrent Pharmaceuticals has market cap of Rs 96,000 Cr and trailing P\/E of 40x at Rs 2,850. 52-week range is Rs 2,600 to Rs 3,700.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_What_are_Torrent_Pharmaceuticalss_growth_catalysts\"><\/span><strong>Q: What are Torrent Pharmaceuticals&#8217;s growth catalysts?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Three key catalysts: India Branded Generic Cardiology, Germany Acquisition, and MR Expansion.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_What_is_Torrent_Pharmaceuticalss_long-term_target\"><\/span><strong>Q: What is Torrent Pharmaceuticals&#8217;s long-term target?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>The Torrent Pharmaceuticals long-term share price target for FY27\u201328 is Rs 4,500 in the bull case \u2014 assuming consistent earnings delivery and full catalyst materialisation.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_Where_can_I_track_Torrent_Pharmaceuticals_live\"><\/span><strong>Q: Where can I track Torrent Pharmaceuticals live?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Track Torrent Pharmaceuticals (NSE: TORNTPHARM) live on the Univest Screener at univest.in\/screeners. Download the Univest App for real-time alerts and SEBI-registered research.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Articles\"><\/span><strong>Recent Articles<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/why-raymonds-share-price-falling\">Why is Raymond\u2019s Share Price Falling?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/why-gacm-technologies-share-price-falling\">Why is the GACM Technologies Share Price Falling?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/why-regaal-resources-share-price-falling\">Why is Regaal Resources Share Price Falling?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/why-mangalore-refinery-petrochemicals-share-price-falling\">Why is Mangalore Refinery &amp; Petrochemicals (MRPL) Share Price Falling?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/why-all-time-plastics-share-price-falling\">Why is All Time Plastics Share Price Falling?<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Torrent Pharmaceuticals (NSE: TORNTPHARM) trades at Rs 2,850 as of April 2026 \u2014 against a 52-week high of Rs 3,700 and a 52-week low of Rs 2,600. The analyst consensus 12-month Torrent Pharmaceuticals share price target is Rs 3,300\u20133,700, implying 16\u201330% upside. This article covers the key catalysts, risks, financial positioning, and a structured bull\/bear<\/p>\n","protected":false},"author":26,"featured_media":71775,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-71762","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"_edit_lock":["1776242648:26"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"rank_math_primary_category":["842"],"rank_math_seo_score":["72"],"rank_math_focus_keyword":["Torrent Pharmaceuticals"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"rank_math_title":["Torrent Pharmaceuticals Share Price Target 2026: Analyst Forecast"],"rank_math_description":[" Torrent Pharmaceuticals (NSE: TORNTPHARM) share price target 2026 \u2014 analyst consensus Rs 3,300\u20133,700. CMP Rs 2,850, bull case Rs 4,500, bear case Rs 2,200. 16\u201330% upside."],"_thumbnail_id":["71775"],"_edit_last":["26"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["8181"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/15141129\/Torrent-Pharma-Share-Price-Target-.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/71762","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=71762"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/71762\/revisions"}],"predecessor-version":[{"id":71776,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/71762\/revisions\/71776"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/71775"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=71762"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=71762"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=71762"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}